Thumbnail Article_Article 3
April 5, 2025

Key Retinal Debates Sizzle in APAO-AIOC 2025 India AAO Symposium

Experts grappled with contemporary retinal topics from firstline treatments in PDR, CSC and myopic tractional maculopathy to OCT-A. The sun…

Thumbnail article _ 1200x675_FDA Approves Neurotech’s ENCELTO for Treatment of Macular Telangiectasia Type 2
March 7, 2025

FDA Approves Neurotech’s ENCELTO for Treatment of Macular Telangiectasia Type 2 

ENCELTO becomes the first and only FDA-approved therapy for macular telangiectasia type 2.  Neurotech Pharmaceuticals (Rhode Island, United States) announced…

latest posts
Thumbnail Article_Article 3
April 5, 2025

Key Retinal Debates Sizzle in APAO-AIOC 2025 India AAO Symposium

Thumbnail article _ 1200x675_FDA Approves Neurotech’s ENCELTO for Treatment of Macular Telangiectasia Type 2
March 7, 2025

FDA Approves Neurotech’s ENCELTO for Treatment of Macular Telangiectasia Type 2 

2
October 19, 2024

AAO 2024 Subspecialty Day Update: Neovascular AMD

Thumbnail_Article Day 3 08
July 26, 2024

New Horizons in Retinopathy of Prematurity Treatment, Tailoring Care for Premature Infants

COVER ART TOC
November 17, 2023

A REVOLUTION in Retinal Therapies: From anti-VEGF to TKIs and gene therapy, cutting-edge innovations are changing the landscape of medical retina

Funny,Halloween,Dog,Wearing,A,Zombie,Bloodshot,Eyes,Glasses.,Isolated
March 30, 2023

Bloodshot Eyes: Cracking the Code of Retinal Vascular Disorders

Close,Up,Of,Eye,Iris,On,Black,Background,,Macro,,Photography
March 10, 2022

The All-Important Macula: E-poster Highlights from RANZCO 2022

The,Sun's,Rays,Over,The,Sea.
February 24, 2022

A Ray of Hope in Retinal Degeneration

Discover our fascinating content at issuu

explore